Corvus Pharmaceuticals (CRVS) Operating Leases (2019 - 2026)
Corvus Pharmaceuticals (CRVS) posted Operating Leases of $274,000 for Q2 2026, down 62.4% from $728,000 a year earlier and down 32.5% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Corvus Pharmaceuticals' Operating Leases came in at $534,000, down 43.0% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of -15.4% (FY2020 to FY2025).
- In prior years, Corvus Pharmaceuticals' Operating Leases was $937,000 in FY2024, $1.37 million in FY2022 (-47.2%) and $2.6 million in FY2021 (+111.1%).
- The Q2 2026 figure stands as the lowest quarterly Operating Leases in data going back to Q1 2019.
- On a year-over-year basis, Operating Leases has declined in each of the last three quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2022, with growth of 216.8%; the weakest was Q3 2023, with a decline of 79.0%.
- According to Business Quant data, Operating Leases for the three prior quarters was $406,000 (Q1 2026), $534,000 (Q4 2025) and $632,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,152.37 Bn | 1,120.96 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 628.86 Bn | 547.39 Bn | 17.26 Bn |
| 3 | AbbVie | 500.37 Bn | 473.48 Bn | 12.70 Bn |
| 4 | Merck | 374.01 Bn | 328.39 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.56 Bn | 264.55 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.92 Bn | 237.60 Bn | 12.86 Bn |
| 7 | Amgen | 238.37 Bn | 193.77 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.21 Bn | 166.40 Bn | 6.22 Bn |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn |
| 10 | Corvus Pharmaceuticals | 932.92 Mn | 421.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 274,000.00 |
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | 534,000.00 |
| Sep 30, 2025 | 632,000.00 |
| Jun 30, 2025 | 728,000.00 |
| Mar 31, 2025 | 834,000.00 |
| Dec 31, 2024 | 937,000.00 |
| Sep 30, 2023 | 354,000.00 |
| Jun 30, 2023 | 700,000.00 |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.69 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.30 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 2.87 Mn |
| Jun 30, 2021 | 631,000.00 |
| Mar 31, 2021 | 935,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 1.51 Mn |
API Access
Corvus Pharmaceuticals Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();